CTD² Data Portal

Principal Investigator 
Stuart L. Schreiber, Ph.D.

Contact
Paul Clemons


 

Select a dataset to view details:

1. Cancer Therapeutics Response Portal (CTRP v1, 2013) Dataset
    
2. Cancer Therapeutics Response Portal (CTRP v2, 2015) Dataset
    
3. Annotated Cluster Multidimensional Enrichment (ACME) Analysis
    
4. Basal Gene-expression and Copy-number Correlation Analysis

Principal Investigator 
Andrea Califano, Ph.D.

Contacts
Multiple Contacts

Select a dataset to view details:

1. Computational Human High-grade Glioblastoma Multiform (GBM) Interactome - miRNA (Post-transcriptional) Layer
    
2. Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia (T-ALL)
    
3. Expression Profile of Neuroendocrine Tumor Cell-line Perturbed with Small Molecules
    
4. PLATE-seq for Genome-wide Regulatory Network Analysis of High-throughput Screens
    
5. Pharmacological Targeting of Mechanistic Dependencies in Neuroendocrine Tumors
    
6. Core Regulatory Elements of High-risk Neuroblastoma
    
7. Proteome-wide Signaling-network Analysis in Lung Adenocarcinoma
    
8. CTD² Pancancer Drug Activity Challenge
    

9. OncoLoop: A Network-based Precision Cancer Medicine Framework
    

10. CTD² Pancancer Chemosensitivity Challenge
     

11. NaRnEA: An Information Theoretic Framework for Gene Set Analysis
     

12. Systematic Elucidation and Pharmacological Targeting of  Tumor-Infiltrating Regulatory T Cell Master Regulators
     

13. A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
     

14. Kinases Controlling Stability of the Oncogenic MYCN Protein

Principal Investigator 
William C. Hahn, M.D., Ph.D.

Contact
Joshua Dempster
 

Select a dataset to view details:

1. Mapping the Function of Rare Oncogenic Variants
    
2. Discovery of Resistance Mechanisms: Breast Cancer
    
3. Discovery of Resistance Mechanisms: Colon Cancer
    
4. Discovery of Novel Oncogenes: Ovarian Cancer
    
5. Discovery of Novel Oncogenes: Across Cancer Types
    
6. Discovery of Novel Oncogenes: High-grade Serous Ovarian Cancer
    
7. Identification of Therapeutic Targets: Adult and Pediatric Cancer Types
    
8. Identification of Therapeutic Targets Across Cancer Types: ATARiS
    
9. Identification of Therapeutic Targets Across Cancer Types: Project Achilles
    
10. Identification of Therapeutic Targets in KRAS Driven Lung Cancer
     
11. Identification of Therapeutic Targets in Ovarian Cancer
     
12. Genome-wide shRNA Screens with DEMETER Inferred Gene Effects
     
13. Computational Correction of Copy-number Effect in CRISPR-Cas9 Screens of Cancer Cells
     
14. SMAD4 Represses FOSL1 Expression and Pancreatic Cancer Metastatic Colonization

Principal Investigator 
Haian Fu, Ph.D.

Contact
Andrey A. Ivanov

Select a dataset to view details:

1. High-throughput Protein-protein Interaction Analysis for Hippo Pathway Profiling
    
2. LC-MS Analysis of PRAS40 Protein-protein Interactions
    
3. High-throughput Protein-protein Interaction Dataset for Lung Cancer-associated Genes
    
4. MEDICI (Mining Essentiality Data to Identify Critical Interactions) for Cancer Drug Target Discovery and Development
    
5. Discovery of Novel MYC Protein Interactors with NanoPCA High-throughput Protein-protein Interaction Screening
    
6. mRNA-seq Analysis of FFPE Prostate Cancer Tissues
    
7. Identification of Protein-protein Interaction Inhibitors as Potential Anti-tumor Immunity Enhancers
    
8. Discovering Protein-protein Interaction (PPI) Inducers to Restore the Lost Function of a Tumor Suppressor
    
9. Discovery of the First Chemical Tools to Regulate MKK3-mediated MYC Activation in Cancer
    

10. Systematic Discovery of Mutation-Directed Neo-Protein-Protein Interactions in Cancer

Principal Investigator 
Christopher Kemp, Ph.D.

Contact
Russell Moser

Select a dataset to view details:

1. Genetic Disruption of CTCF Destabilizes DNA Methylation
    
2. Functional Landscape of the Human Kinome in MYCN Amplified and Non-amplified Neuroblastoma
    
3. Identification of Drug Targets for Combination Therapy with Retinoic Acid in Neuroblastoma
    
4. Functional Exploration of the Druggable Genome in MYCN Amplified and Non-amplified Neuroblastoma
    
5. Identification of Candidate Therapeutic Targets in Head and Neck Cancer Using Functional Kinomics
    
6. Kinome-wide siRNA Screens (screen 1) to Discover Novel Vulnerabilities in Ras/Tp53 Mutant Murine Squamous Cell Carcinomas
    
7. Functional Exploration of the Druggable Genome in Cisplatin Resistant Ovarian Cancer
    
8. Functional Exploration of the Kinome in MYC Driven Ovarian Cancer
    
9. Functional Exploration of the Kinome in Pancreatic Ductal Adenocarcinoma
    
10. Functional Exploration of the Druggable Genome in Pancreatic Ductal Adenocarcinoma
     
11. Functional Exploration of the Druggable Genome in Head and Neck Squamous Cell Carcinoma
     
12. Kinome-wide siRNA Screens (screen 2) to Discover Novel Vulnerabilities in Ras/Tp53 Mutant Murine Squamous Cell Carcinomas
     
13. Identification of Novel Targets and Sensitizers to the PARP Inhibitor Rucaparib in Ovarian Cancer

Principal Investigator 
Martin McIntosh, Ph.D.

Contact
Martin McIntosh

Select a dataset to view details:

1. Transcript Splicing in Ovarian Cancer and in Diverse Normal Tissues
    
2. NanoString Profiling of MUC16 in Serous Ovarian Cancer, Benign Ovarian Tumor and Normal Tissues
    
3. Spectral Nature of Fusion Transcripts in Serous Ovarian Cancer

Principal Investigator 
Joel S. Bader, Ph.D.

Contacts
Joel Bader
(computational methods)

Andrew Ewald
(wet-lab methods)

Select a dataset to view details:

1. E-cadherin Promotes Metastasis in Invasive Ductal Breast Cancer
    
2. Organoid Spectral Invasion and Population Genetics

Principal Investigator 
Brian J. Druker, M.D.

Contacts
Multiple Contacts

Select the dataset to view more details:

1. Functional Genomic Landscape of Acute Myeloid Leukaemia
    
2. Secondary Fusion Proteins as a Mechanism of BCR::ABL1 Kinase-independent Resistance in Chronic Myeloid Leukaemia

Principal Investigator 
Gordon Mills, M.D., Ph.D.

Contacts
Multiple Contacts

Select the dataset to view details:

1. Large-scale Characterization of Drug Responses for Clinically Relevant Proteins in Cancer Cell Lines
    
2. In Vivo Functional Characterization of EGFR Variants Identifies Novel Drivers of Glioblastoma
    
3. Tumor-intrinsic SIRPA Promotes Sensitivity to Checkpoint Inhibition Immunotherapy in Melanoma

Principal Investigators 
Calvin J. Kuo, M.D., Ph.D.
Hanlee Ji, M.D.

Contacts
Multiple Contacts

Select a dataset to view details:

1. Identifying Methylation-driven Genes in Colorectal Cancer
    
2. Organoid Modeling of the Tumor Immune Microenvironment
    
3. Quantifying the Timing of Metastatic Progression from Patient Genomic Data
    
4. Single-cell Genomic Characterization of the Tumor Microenvironment of Gastric Cancer
    
5. Predicting DNA Methylation Patterns using Histopathology Images
    
6. A CRISPR/Cas9-engineered ARID1A-deficient Human Gastric Cancer Organoid Model Reveals Essential and Non-essential Modes of Oncogenic Transformation
    
7. Tumor Microenvironment of Metastatic Colorectal Cancer
    
8. Functional Screening of Amplification Outlier Oncogenes in Organoid Models of Early Tumorigenesis

Principal Investigator 
Michael E. Berens, Ph.D.

Contact
Sen Peng

Select a dataset to view details:

1. Glioblastoma Multiforme Orthotopic Xenograft Transcriptome
    
2. Identification of Pathways Enriched with Condition-specific Statistical Dependencies Across Four Subtypes of Glioblastoma Multiforme (GBM)
    
3. Quantified Cancer Cell Line Encyclopedia RNA-seq Data

Principal Investigator 
Michael McManus, Ph.D.

Contact
Sourav Bandyopadhyay

Select a dataset to view details:

1. Chemical-genetic Interaction Mapping Strategy
    
2. Construction of Directional Regulatory Networks Using Orthogonal CRISPR/Cas Screens
    
3. A Quantitative Chemical-genetic Interaction Map of Cancer Chemotherapy

Principal Investigator 
William A. Weiss, M.D., Ph.D.

Contact
David Quigley

Select a dataset to view details:

1. Integrative Genomic Approaches in Neuroblastoma (NBL)
    

2. Expression Analysis of Superior Cervical Ganglion from Backcrossed TH-MYCN Transgenic Mice
    

3. Gene Expression Profiling of Normal Mouse Skin, Hras WT and Hras -/-
    

4. Human Neuroepithelial Stem Cells as a Model System for Medulloblastoma

Principal Investigator 
Gordon B. Mills, M.D., Ph.D.

Contact
Prahlad Ram

Select a dataset to view details:

1. Characterization of PIK3R1 Neomorphic Mutations
    
2. High-throughput Screening Identifying Driving Mutations in Endometrial Cancer
    
3. Phenotypic Examination of PIK3CA Allelic Series Using MCF10A Cell Sensor Platform
    
4. Systematic Functional Annotation of Somatic Mutations in Cancer
    

5. Informer Drug Library Screening Against Patient-derived PDGFRA Mutations

Principal Investigator 
Michael Roth, Ph.D.

Contact
Bruce Posner

Select a dataset to view details:

1. Lung Cancer Oncogenotype-selective Drug Target Discovery (Natural Products Focus)
    
2. Functional Signature Ontology Tool: Triplicate Measurements of Reporter Gene Expression in Response to Individual Genetic and Chemical Perturbations in HCT116 Cells (Colon Cancer)
    
3. U01 Natural Products Screening
    
4. High-throughput siRNA Screening of a Non-small Cell Lung Cancer (NSCLC) Cell Line Panel
    
5. Identification of ASCL1 as a Therapeutic Target for High-grade Neuroendocrine Lung Cancers
    
6. SW04428 is a Novel Topoisomerase 1 Inhibitor
    
7. NSCLC Cell Lines with Loss of SMARCA4 Expression are Hypersensitive to Inhibitors of Aurora Kinase A
    
8. DRC Study of Natural Products Against Non-small Cell Lung Cancer (NSCLC) Cell Lines
    

9. High-throughput Screening of CTD² Network Informer Set (CNIS) Compounds Against Non-Small-Cell Lung Cancer (NSCLC) Cell Lines